A randomized, sham-controlled clinical trial to evaluate the NET Device™ for reducing withdrawal symptom severity during opioid discontinuation - Greenwald MK; Arfken CL; Winston JR (Frontiers in Psychiatry, 2025)
FEMU ID: 59109; EMF-Portal URL: https://www.emf-portal.org/en/article/59109